Total Payments
$40,982
2024 Payments
$55.75
Companies
10
Transactions
23
Payment Breakdown by Category
Research$29,088 (71.0%)
Consulting$9,465 (23.1%)
Travel$1,176 (2.9%)
Food & Beverage$1,153 (2.8%)
Education$99.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $29,088 | 4 | 71.0% |
| Consulting Fee | $9,465 | 2 | 23.1% |
| Travel and Lodging | $1,176 | 3 | 2.9% |
| Food and Beverage | $1,153 | 13 | 2.8% |
| Education | $99.00 | 1 | 0.2% |
Payments by Type
Research
$29,088
4 transactions
General
$11,894
19 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $29,088 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $10,434 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $600.00 | 1 | $0 (2020) |
| Medtronic MiniMed, Inc. | $268.77 | 4 | $0 (2018) |
| Medtronic, Inc. | $215.48 | 2 | $0 (2023) |
| Senseonics, Incorporated | $118.00 | 1 | $0 (2019) |
| AbbVie, Inc. | $105.04 | 1 | $0 (2019) |
| PFIZER INC. | $99.00 | 1 | $0 (2017) |
| Novo Nordisk Inc | $31.97 | 1 | $0 (2024) |
| Amylyx Pharmaceuticals, Inc. | $21.67 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55.75 | 2 | Novo Nordisk Inc ($31.97) |
| 2023 | $39,735 | 13 | SANOFI US SERVICES INC. ($29,088) |
| 2020 | $600.00 | 1 | Daiichi Sankyo Inc. ($600.00) |
| 2019 | $223.04 | 2 | Senseonics, Incorporated ($118.00) |
| 2018 | $81.31 | 1 | Medtronic MiniMed, Inc. ($81.31) |
| 2017 | $286.46 | 4 | Medtronic MiniMed, Inc. ($187.46) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $31.97 | General |
| 12/14/2023 | SANOFI US SERVICES INC. | TZIELD (Biological) | — | Cash or cash equivalent | $28,651.96 | Research |
| Study: A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus • Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2023 | SANOFI US SERVICES INC. | TZIELD (Biological) | — | Cash or cash equivalent | $218.00 | Research |
| Study: A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus • Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2023 | SANOFI US SERVICES INC. | TZIELD (Biological) | — | Cash or cash equivalent | $109.00 | Research |
| Study: A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus • Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2023 | SANOFI US SERVICES INC. | TZIELD (Biological) | — | Cash or cash equivalent | $109.00 | Research |
| Study: A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus • Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $8,865.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $592.59 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $376.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $220.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $207.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/01/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $148.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/31/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $86.01 | General |
| Category: Durable Pump | ||||||
| 05/23/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $129.47 | General |
| Category: Durable Pump | ||||||
| 02/17/2023 | Amylyx Pharmaceuticals, Inc. | RELYVRIO (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NEUROLOGY | ||||||
| 09/22/2020 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 03/05/2019 | Senseonics, Incorporated | Eversense (Device) | Food and Beverage | Cash or cash equivalent | $118.00 | General |
| Category: Endocrinology | ||||||
| 02/05/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $105.04 | General |
| Category: Endocrinology | ||||||
| 01/03/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $81.31 | General |
| Category: Durable Pump | ||||||
| 06/06/2017 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Durable Pump | ||||||
| 05/19/2017 | PFIZER INC. | GENOTROPIN (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 01/28/2017 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Durable Pump | ||||||
| 01/19/2017 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $51.10 | General |
| Category: Durable Pump | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus | SANOFI US SERVICES INC. | $29,088 | 4 |
About Dr. Neil White, MD
Dr. Neil White, MD is a Pediatrics healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558388017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neil White, MD has received a total of $40,982 in payments from pharmaceutical and medical device companies, with $55.75 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "" ($29,088).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Endocrinology
- Location Saint Louis, MO
- Active Since 07/17/2006
- Last Updated 04/25/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1558388017
Products in Payments
- TZIELD (Biological) $39,522
- Minimed 670G System (Device) $268.77
- MINIMED 780G (Device) $215.48
- Eversense (Device) $118.00
- Lupron Depot (Drug) $105.04
- GENOTROPIN (Drug) $99.00
- RELYVRIO (Drug) $21.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Saint Louis
Dr. Philip Spinella, Md, MD
Pediatrics — Payments: $286,187
Pediatrics $286,187
Dr. David Balzer, Md, MD
Pediatrics — Payments: $209,718
Pediatrics $209,718
Dr. Amy Clark, Do, DO
Pediatrics — Payments: $129,192
Pediatrics $129,192
Dr. Jennifer Silva, Md, MD
Pediatrics — Payments: $128,336
Pediatrics $128,336
Dr. Nico Dosenbach, Md, MD
Pediatrics — Payments: $115,400
Pediatrics $115,400
Dr. Kel Vin Woo, M.d., Ph.d, M.D., PH.D
Pediatrics — Payments: $100,017
Pediatrics $100,017